Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk - PubMed (original) (raw)
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
M A Austin et al. Circulation. 1990 Aug.
Abstract
In a community-based study of 301 subjects from 61 nuclear families, two distinct phenotypes (denoted A and B) were identified by nondenaturing gradient gel electrophoretic analysis of low density lipoprotein (LDL) subclasses. Phenotype A was characterized by predominance of large, buoyant LDL particles, and phenotype B consisted of a major peak of small, dense LDL particles. Previous analysis of the family data by complex segregation analysis demonstrated that these phenotypes appear to be inherited as a single-gene trait. In the present study, the phenotypes were found to be closely associated with variations in plasma levels of other lipid, lipoprotein, and apolipoprotein measurements. Specifically, phenotype B was associated with increases in plasma levels of triglyceride and apolipoprotein B, with mass of very low and intermediate density lipoproteins, and with decreases in high density lipoprotein (HDL) cholesterol, HDL2 mass, and plasma levels of apolipoprotein A-I. Thus, the proposed genetic locus responsible for LDL subclass phenotypes also results in an atherogenic lipoprotein phenotype.
Comment in
- New lipoprotein profiles and coronary heart disease. Improving precision of risk.
Nestel PJ. Nestel PJ. Circulation. 1990 Aug;82(2):649-51. doi: 10.1161/01.cir.82.2.649. Circulation. 1990. PMID: 2372911 No abstract available.
Similar articles
- Genetic epidemiology of low-density lipoprotein subclass phenotypes.
Austin MA. Austin MA. Ann Med. 1992 Dec;24(6):477-81. doi: 10.3109/07853899209166999. Ann Med. 1992. PMID: 1485942 Review. - HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S, Dostal E, Dukát A, Gavorník P, Kucera M, Gruber K. Oravec S, et al. Neuro Endocrinol Lett. 2011;32(4):502-9. Neuro Endocrinol Lett. 2011. PMID: 21876506 Clinical Trial. - Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
Griffin BA, Minihane AM, Furlonger N, Chapman C, Murphy M, Williams D, Wright JJ, Williams CM. Griffin BA, et al. Clin Sci (Lond). 1999 Sep;97(3):269-76. Clin Sci (Lond). 1999. PMID: 10464051 - Characterization of low-density lipoprotein subclasses in children.
Arisaka O, Fujiwara S, Yabuta K, Mokuno H, Mitugi Y, Miyake N. Arisaka O, et al. Metabolism. 1997 Feb;46(2):146-8. doi: 10.1016/s0026-0495(97)90292-4. Metabolism. 1997. PMID: 9030819 - Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease.
Austin MA, Hokanson JE. Austin MA, et al. Med Clin North Am. 1994 Jan;78(1):99-115. doi: 10.1016/s0025-7125(16)30178-x. Med Clin North Am. 1994. PMID: 8283937 Review.
Cited by
- The effect of upper- and lower-body exercise on next-day postprandial triglycerides in healthy young men.
Zhong Z, Miyachi M, Tanisawa K. Zhong Z, et al. Front Physiol. 2024 Sep 30;15:1454731. doi: 10.3389/fphys.2024.1454731. eCollection 2024. Front Physiol. 2024. PMID: 39403562 Free PMC article. - Obesity Parameters as Predictor of Poor Outcomes in Hospitalized Patients with Confirmed Mild-to-Moderate COVID-19.
Barus NRV, Tahapary DL, Kurniawan F, Sinto R, Wafa S, Wisnu W, Mansjoer A, Wijaya CN, Felix I, Tarigan TJE, Harbuwono DS, Soewondo P. Barus NRV, et al. Infect Dis Rep. 2024 Sep 12;16(5):894-905. doi: 10.3390/idr16050071. Infect Dis Rep. 2024. PMID: 39311212 Free PMC article. - Prevalence and burden of coronary artery disease on computed tomography coronary angiography and its correlation with high-density lipoprotein in the Northern Territory, Australia.
Baumann AAW, Roberts-Thomson RL, Shah R, Reynolds GF, Marangou J, Tayeb H, Psaltis PJ, Brown A, Wong D, Kangaharan N, Ilton M. Baumann AAW, et al. Cardiovasc Diagn Ther. 2024 Aug 31;14(4):725-730. doi: 10.21037/cdt-23-458. Epub 2024 Aug 5. Cardiovasc Diagn Ther. 2024. PMID: 39263474 Free PMC article. - Non-Pharmacological Treatment for Cardiovascular Risk Prevention in Children and Adolescents with Obesity.
Genovesi S, Vania A, Caroli M, Orlando A, Lieti G, Parati G, Giussani M. Genovesi S, et al. Nutrients. 2024 Jul 31;16(15):2497. doi: 10.3390/nu16152497. Nutrients. 2024. PMID: 39125377 Free PMC article. Review. - Opinion: Are mental health benefits of the ketogenic diet accompanied by an increased risk of cardiovascular disease?
Diamond DM, Mason P, Bikman BT. Diamond DM, et al. Front Nutr. 2024 May 1;11:1394610. doi: 10.3389/fnut.2024.1394610. eCollection 2024. Front Nutr. 2024. PMID: 38751739 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources